AUTOIMMUNE PHENOMENA IN CHILDREN WITH CHRONIC
VIRAL HEPATITIS (HCV, HBV)
G. VERUCCHI, M LENZI*, L ATTARD, P
MURATORI*, S DIOTALLEVI, R MINERO§, F GUZZO, F BIANCHI*, F
CHIODO Dep.of Clinical and Experimental-Division of Infectious
Diseases-University of Bologna, *Internal Medicine - University of
Bologna, § Dep. of Clinical Pathology- S.Orsola Hospital -
Bologna - Italy
The relationship between hepatitis virus
infections (HCV and HBV) and autoimmune phenomena (ANA, SMA,
anti-LKM1, anti-LC1, a ti-Thyroid-Peroxidase-anti-TPO and
anti-Thyroglobulin-anti-TG) are still poorly investigated in
children.
Aim of the study:
to assess the prevalence of non organ and organ specific
autoantibodies in a retrospective series of children with HCV and
HBV-chronic infection.
Patients and Methods:
36 patients with anti-HCV and HCV-RNA positive chronic hepatitis
(18 males, 18 females) with a median age of 8.9 years (range
2-15,8) were studied, Twenty-two patients received blood or plasma
transfusion, 11 were borm from anti-HCV positive mothers,one had
major surgery and in two the route of infection was unknown. As a
control group, sera from 42 children (23M/19F) (median age 9,4
years-range 2,5-15,11) with HBV infection (33 HBV-DNA positive)
were considered. Sera were tested at a dilution of 1:20 on liver,
kidney and stomach cryostat sections and on Hep-2 cell. Anti-LC1
antibody was tested by CIE with rat liver cytosol as source of
antigen. Anti-Thyroid Peroxidase and anti-Thyroglobulin antibodies
were tested by a commercially RIA-Kit. Results: non organ-specific
autoantibodies were detected in 10 out of 36 patients with HCV
infection (28%) and in 5 out of 42 children with HBV infection
(12%). The prevalence of each autoantibodies is shown in the
table
HCV (36) HBV (42)
ANA (speckled) 1 3% 2 5%
SMA (non anti-actin) 5 14% 3 7%
Anti-LKM1 4 11% 0 -
Anti-LC1 0 - 0 -
Anti-TPO 1/29 3% 0/27 -
Anti-TG 0/29 - 0/27 -
Clinical and biochermical differences did
not emerge between autoantibodies positive and negative patients.
No specific association was found between HCV genotypes and one of
the autoantibodies studied. Four (3 SMA, 1 ANA) out of 12 patients
with HCV chronic hepatitis and 1 (ANA) out of 19 children with HBV
chronic hepatitis who underwent interferon therapy developed low
titres of autoantibodies under treatment.
Conclusions:
These results demonstrate that overall prevalence of non organ
specific autoantibodies is higher in children with HCV -related
chronic hepatitis than that observed in HBV -related ones, and
similar to that observed in adults. The autoantibodies
specificities typical of autoimmune hepatitis were never observed
in these patients. Anti-LKM1 reactivity is specific of anti-HCV
infection and its prevalence is higher than that reported in
adults.
Source: American Association for the
Study of Liver Diseases - 1996 Annual Meeting
Back to A Hepatitis C
Primer
|